Strain identifier

BacDive ID: 1691

Type strain: No

Species: Bifidobacterium bifidum

Strain Designation: E319f (Variant a), 319f

Strain history: CIP <- 1964, Lab. Ident. Inst. Pasteur, Paris, France <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain 319f

NCBI tax ID(s): 398514 (strain), 1681 (species)

« back to strain detail view
For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 8.1 (current version)

General

@ref: 8509

BacDive-ID: 1691

DSM-Number: 20082

keywords: genome sequence, 16S sequence, Bacteria, anaerobe, mesophilic

description: Bifidobacterium bifidum E319f is an anaerobe, mesophilic bacterium that was isolated from intestine of adult.

NCBI tax id

NCBI tax idMatching level
398514strain
1681species

strain history

@refhistory
8509<- G. Reuter, E319f (Variant a)
67770DSM 20082 <-- G. Reuter E319f (Variant a).
116807CIP <- 1964, Lab. Ident. Inst. Pasteur, Paris, France <- M. Sebald, Inst. Pasteur, Paris, France <- H. Werner <- G. Reuter: strain 319f

doi: 10.13145/bacdive1691.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/actinomycetota
  • domain: Bacteria
  • phylum: Actinomycetota
  • class: Actinomycetes
  • order: Bifidobacteriales
  • family: Bifidobacteriaceae
  • genus: Bifidobacterium
  • species: Bifidobacterium bifidum
  • full scientific name: Bifidobacterium bifidum (Tissier 1900) Orla-Jensen 1924 (Approved Lists 1980)

  • synonyms

    @refsynonym
    20215Bacillus bifidus
    20215Bacterium bifidum

@ref: 8509

domain: Bacteria

phylum: Actinobacteria

class: Actinobacteria

order: Bifidobacteriales

family: Bifidobacteriaceae

genus: Bifidobacterium

species: Bifidobacterium bifidum

full scientific name: Bifidobacterium bifidum (Tissier 1900) Orla-Jensen 1924 emend. Nouioui et al. 2018

strain designation: E319f (Variant a), 319f

type strain: no

Morphology

cell morphology

@refmotilityconfidencegram staincell shape
69480no95.65
6948099.72positive
116807nopositiverod-shaped

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
8509BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58)yeshttps://mediadive.dsmz.de/medium/58Name: BIFIDOBACTERIUM MEDIUM (DSMZ Medium 58) Composition: Glucose 10.0 g/l Casein peptone 10.0 g/l Bacto Soytone 5.0 g/l Meat extract 5.0 g/l Yeast extract 5.0 g/l L-Cysteine HCl x H2O 0.5 g/l NaHCO3 0.4 g/l NaCl 0.08 g/l MnSO4 x H2O 0.05 g/l KH2PO4 0.04 g/l K2HPO4 0.04 g/l MgSO4 x 7 H2O 0.02 g/l CaCl2 x 2 H2O 0.01 g/l Tween 80 Resazurin Distilled water
36043MEDIUM 20 - for Anaerobic bacteriayesAgar (15.000 g);Glucose (5.000 g);Yeast extract (20.000 g);Tryptone (30.000 g);Cysteine hydrochloride (0.500 g);distilled water (1000.000 ml);Hemin solution -M00149 (25.000 ml)
116807CIP Medium 72yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=72
116807CIP Medium 20yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=20

culture temp

@refgrowthtypetemperaturerange
8509positivegrowth37mesophilic
36043positivegrowth37mesophilic
67770positivegrowth37mesophilic

Physiology and metabolism

oxygen tolerance

@refoxygen toleranceconfidence
8509anaerobe
69480anaerobe96.478
116807anaerobe

spore formation

@refspore formationconfidence
69481no100
69480no99.99

murein

  • @ref: 8509
  • murein short key: A21.08
  • type: A4ß L-Orn(L-Lys)-D-Ser-D-Asp

metabolite utilization

@refmetaboliteutilization activitykind of utilization testedChebi-ID
68371Potassium 2-ketogluconate-builds acid from
68371gluconate-builds acid from24265
68371L-arabitol-builds acid from18403
68371D-arabitol-builds acid from18333
68371L-fucose-builds acid from18287
68371D-fucose-builds acid from28847
68371D-tagatose-builds acid from16443
68371D-lyxose-builds acid from62318
68371turanose-builds acid from32528
68371gentiobiose-builds acid from28066
68371xylitol-builds acid from17151
68371glycogen-builds acid from28087
68371starch-builds acid from28017
68371raffinose-builds acid from16634
68371melezitose-builds acid from6731
68371inulin-builds acid from15443
68371trehalose-builds acid from27082
68371sucrose-builds acid from17992
68371melibiose-builds acid from28053
68371maltose-builds acid from17306
68371cellobiose-builds acid from17057
68371salicin-builds acid from17814
68371esculin-builds acid from4853
68371arbutin-builds acid from18305
68371amygdalin-builds acid from27613
68371N-acetylglucosamine-builds acid from59640
68371methyl alpha-D-glucopyranoside-builds acid from320061
68371methyl alpha-D-mannoside-builds acid from43943
68371D-sorbitol-builds acid from17924
68371D-mannitol-builds acid from16899
68371myo-inositol-builds acid from17268
68371galactitol-builds acid from16813
68371L-rhamnose-builds acid from62345
68371L-sorbose-builds acid from17266
68371D-mannose-builds acid from16024
68371D-glucose-builds acid from17634
68371D-galactose-builds acid from12936
68371methyl beta-D-xylopyranoside-builds acid from74863
68371ribitol-builds acid from15963
68371L-xylose-builds acid from65328
68371D-xylose-builds acid from65327
68371D-ribose-builds acid from16988
68371L-arabinose-builds acid from30849
68371D-arabinose-builds acid from17108
68371erythritol-builds acid from17113
68371glycerol-builds acid from17754
116807nitrate-reduction17632
116807nitrite-reduction16301

metabolite production

  • @ref: 116807
  • Chebi-ID: 35581
  • metabolite: indole
  • production: no

enzymes

@refvalueactivityec
68382alpha-fucosidase-3.2.1.51
68382alpha-mannosidase-3.2.1.24
68382N-acetyl-beta-glucosaminidase+3.2.1.52
68382beta-glucosidase-3.2.1.21
68382alpha-glucosidase-3.2.1.20
68382beta-glucuronidase-3.2.1.31
68382beta-galactosidase+3.2.1.23
68382alpha-galactosidase+3.2.1.22
68382naphthol-AS-BI-phosphohydrolase-
68382acid phosphatase+3.1.3.2
68382alpha-chymotrypsin-3.4.21.1
68382trypsin-3.4.21.4
68382cystine arylamidase-3.4.11.3
68382valine arylamidase-
68382leucine arylamidase+3.4.11.1
68382lipase (C 14)-
68382esterase lipase (C 8)+
68382esterase (C 4)+
68382alkaline phosphatase-3.1.3.1
116807oxidase-
116807catalase-1.11.1.6
116807urease-3.5.1.5

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
116807--++-+----+-++---+--

API 50CHac

@refGLYERYDARALARARIBDXYLLXYLADOMDXGALGLUFRUMNESBERHADULINOMANSORMDMMDGNAGAMYARBESCSALCELMALLACMELSACTREINUMLZRAFAMDGLYGXLTGENTURLYXTAGDFUCLFUCDARLLARLGNT2KG5KG
116807-----------+/-----------------+/--------------------+/-

Isolation, sampling and environmental information

isolation

@refsample type
8509intestine of adult
67770Intestine of adult
116807Human, Intestine of adult

isolation source categories

  • Cat1: #Host Body-Site
  • Cat2: #Gastrointestinal tract

Safety information

risk assessment

@refbiosafety levelbiosafety level comment
85091Risk group (German classification)
1168071Risk group (French classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Bifidobacterium bifidum gene for 16S rRNA, partial sequence, strain: JCM 1254AB116282478ena398514
20218Bifidobacterium bifidum gene for 16S rRNA, partial sequence, strain: JCM 1254AB507077687ena398514
20218Bifidobacterium bifidum strain DSM 20082 16S ribosomal RNA gene and 16S-23S ribosomal RNA intergenic spacer, partial sequenceJQ347258743ena1681

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Bifidobacterium bifidum JCM 1254398514.4wgspatric398514
66792Bifidobacterium bifidum JCM 12542675903332draftimg398514
67770Bifidobacterium bifidum JCM 1254GCA_001311705contigncbi398514
66792Bifidobacterium bifidum JCM 1254GCA_024341745contigncbi398514

GC content

@refGC-contentmethod
850961.6
6777061.1thermal denaturation, midpoint method (Tm)

Genome-based predictions

predictions

traitpredictionconfidencetraining_data
spore-formingno100no
gram-positiveyes93.266no
anaerobicyes97.192yes
halophileno78.238no
spore-formingno97.137no
glucose-utilyes87.651no
aerobicno95.498yes
motileno93.401no
flagellatedno96.978no
thermophileno97.617yes
glucose-fermentyes84.442no

External links

@ref: 8509

culture collection no.: DSM 20082, JCM 1254, BCRC 11844, CIP 64.64, KCTC 3440, CCUG 45218

straininfo link

  • @ref: 71338
  • straininfo: 7403

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Metabolism1285646High-affinity oxygen uptake by Bifidobacterium bifidum.Cox RP, Marling NAntonie Van Leeuwenhoek10.1007/BF005725971992Bifidobacterium/*metabolism, Kinetics, Multienzyme Complexes/*metabolism, Myoglobin/metabolism, NADH, NADPH Oxidoreductases/*metabolism, Oxidation-Reduction, *Oxygen Consumption, Spectrophotometry, UltravioletEnzymology
Metabolism8640105Characterization of the lactose transport system in the strain Bifidobacterium bifidum DSM 20082.Krzewinski F, Brassart C, Gavini F, Bouquelet SCurr Microbiol10.1007/s0028499000541996Bifidobacterium/enzymology/growth & development/*metabolism, Biological Transport/drug effects, Carbonyl Cyanide m-Chlorophenyl Hydrazone/pharmacology, Culture Media/chemistry, Dicyclohexylcarbodiimide/pharmacology, Enzyme Induction, Enzyme Inhibitors/*pharmacology, Lactose/*metabolism, Sodium Fluoride/pharmacology, beta-Galactosidase/biosynthesisEnzymology
Metabolism9236301Glucose and galactose transport in Bifidobacterium bifidum DSM 20082.Krzewinski F, Brassart C, Gavini F, Bouquelet SCurr Microbiol10.1007/s0028499002341997Bifidobacterium/*metabolism, Biological Transport, Galactose/*metabolism, Glucose/*metabolism, Phosphorylation
Metabolism9889079Beta-1,3-galactosyl-N-acetylhexosamine phosphorylase from Bifidobacterium bifidum DSM 20082: characterization, partial purification and relation to mucin degradation.Derensy-Dron D, Krzewinski F, Brassart C, Bouquelet SBiotechnol Appl Biochem1999Animals, Bacterial Proteins/isolation & purification/metabolism, Bifidobacterium/*enzymology, Carbohydrate Conformation, Carbohydrate Sequence, Disaccharides/metabolism, Galactosephosphates/chemistry/metabolism, Galactosyltransferases/chemistry/*isolation & purification/*metabolism, Hydrogen-Ion Concentration, Molecular Sequence Data, Mucins/*metabolism, Phosphorylation, Substrate Specificity, Swine, TemperatureEnzymology
Cultivation10361675Complementary effects of bifidogenic growth stimulators and ammonium sulfate in natural rubber serum powder on Bifidobacterium bifidum.Etoh S, Sonomoto K, Ishizaki ABiosci Biotechnol Biochem10.1271/bbb.63.6271999Ammonium Sulfate/*pharmacology, Bifidobacterium/drug effects/*growth & development/*metabolism, Carbohydrates/*pharmacology, Chromatography, High Pressure Liquid, Culture Media, Molecular Weight, Powders, Proteins/*pharmacology, Rubber, Stimulation, Chemical, Ultrafiltration, Vitamin B 12/pharmacologyPathogenicity
Enzymology11129579Purification and identification of a growth-stimulating peptide for Bifidobacterium bifidum from natural rubber serum powder.Etoh S, Asamura K, Obu A, Sonomoto K, Ishizaki ABiosci Biotechnol Biochem10.1271/bbb.64.20832000Amino Acid Sequence, Bifidobacterium/*chemistry, Chromatography, Gel, Growth Substances/chemistry/*isolation & purification, Peptides/chemistry/*isolation & purification, Rubber/*chemistry, Spectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationPhylogeny
Enzymology17587697Identification of the putative proton donor residue of lacto-N-biose phosphorylase (EC 2.4.1.211).Nishimoto M, Kitaoka MBiosci Biotechnol Biochem10.1271/bbb.700642007Amino Acids, Bifidobacterium/*enzymology/genetics, Cloning, Molecular, Conserved Sequence, Isoenzymes, Molecular Sequence Data, Mutation, Phosphorylases/*genetics/metabolism, ProtonsGenetics
Metabolism17943273Characterisation of glutamine fructose-6-phosphate amidotransferase (EC 2.6.1.16) and N-acetylglucosamine metabolism in Bifidobacterium.Foley S, Stolarczyk E, Mouni F, Brassart C, Vidal O, Aissi E, Bouquelet S, Krzewinski FArch Microbiol10.1007/s00203-007-0307-92007Acetylglucosamine/*metabolism, Amino Acid Sequence, Bacterial Proteins/chemistry/genetics/isolation & purification/*metabolism, Bifidobacterium/*enzymology/genetics/*metabolism, Catalytic Domain, Cloning, Molecular, Conserved Sequence, Enzyme Stability, Escherichia coli/genetics, Fructosephosphates/metabolism, Gene Expression, Glucosamine/analogs & derivatives/metabolism, Glucose-6-Phosphate/analogs & derivatives/metabolism, Glutamic Acid/metabolism, Glutaminase/metabolism, Glutamine/metabolism, Hydrogen-Ion Concentration, Metabolic Networks and Pathways, Models, Biological, Molecular Sequence Data, Sequence Analysis, DNA, Sequence Homology, Amino Acid, TemperatureEnzymology
Metabolism18469123Bifidobacterium bifidum lacto-N-biosidase, a critical enzyme for the degradation of human milk oligosaccharides with a type 1 structure.Wada J, Ando T, Kiyohara M, Ashida H, Kitaoka M, Yamaguchi M, Kumagai H, Katayama T, Yamamoto KAppl Environ Microbiol10.1128/AEM.00149-082008Amino Acid Sequence, Bacterial Proteins/chemistry/genetics/metabolism, Bifidobacterium/classification/*enzymology, DNA, Bacterial/analysis/isolation & purification, Glycoside Hydrolases/chemistry/genetics/*metabolism, Humans, Mass Spectrometry/methods, Milk, Human/chemistry/*metabolism, Molecular Sequence Data, Oligosaccharides/chemistry/*metabolism, Recombinant Proteins/genetics/metabolism, Sequence Analysis, DNA, Substrate SpecificityEnzymology
Metabolism19172489Effect of Bifidobacterium bifidum DSM 20082 cytoplasmic fraction on human immune cells.Mouni F, Aissi E, Hernandez J, Gorocica P, Bouquelet S, Zenteno E, Lascurain R, Garfias YImmunol Invest10.1080/088201308026083032009Apoptosis/immunology, Bifidobacterium/immunology/*metabolism/ultrastructure, CD4 Antigens/genetics/immunology/*metabolism, CD8 Antigens/genetics/immunology/*metabolism, CD8-Positive T-Lymphocytes/cytology/immunology/*metabolism, Cell Fractionation, Cell Proliferation, Cell Separation, Cytoplasm/immunology/metabolism, Cytotoxicity, Immunologic/drug effects, Dose-Response Relationship, Immunologic, Flow Cytometry, Humans, Peanut Agglutinin/metabolism, Plant Preparations/pharmacologyPathogenicity
Enzymology19520709Two distinct alpha-L-fucosidases from Bifidobacterium bifidum are essential for the utilization of fucosylated milk oligosaccharides and glycoconjugates.Ashida H, Miyake A, Kiyohara M, Wada J, Yoshida E, Kumagai H, Katayama T, Yamamoto KGlycobiology10.1093/glycob/cwp0822009Animals, Bifidobacterium/*enzymology, Chromatography, Affinity, Electrophoresis, Polyacrylamide Gel, Fucose/*metabolism, Glycoconjugates/*metabolism, Isoenzymes/isolation & purification/*metabolism, *Milk, Oligosaccharides/*metabolism, Substrate Specificity, alpha-L-Fucosidase/isolation & purification/*metabolismMetabolism
Metabolism21036948An exo-alpha-sialidase from bifidobacteria involved in the degradation of sialyloligosaccharides in human milk and intestinal glycoconjugates.Kiyohara M, Tanigawa K, Chaiwangsri T, Katayama T, Ashida H, Yamamoto KGlycobiology10.1093/glycob/cwq1752010Amino Acid Sequence, Bifidobacterium/*enzymology, Cloning, Molecular, Enzyme Assays, Enzyme Stability, Glycosylation, Humans, Milk, Human/*metabolism, Molecular Sequence Data, N-Acetylneuraminic Acid/metabolism, Neuraminidase/*chemistry/genetics/metabolism, Oligosaccharides/*metabolism, Phylogeny, Recombinant Proteins/*chemistry/genetics/metabolism, Sequence Alignment, Substrate Specificity, TemperatureEnzymology
Metabolism21832085Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria.Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J, Kitaoka MJ Biol Chem10.1074/jbc.M111.2481382011Adult, Bifidobacteriales Infections/microbiology, Bifidobacterium/*metabolism, Carbohydrates/chemistry, Chromatography, High Pressure Liquid/methods, Female, Gastrointestinal Tract/microbiology, Humans, Infant, Newborn, Intestines/*microbiology, Japan, Milk, Human/*metabolism, Molecular Sequence Data, Monosaccharides, Oligosaccharides/chemistry/*metabolism, Time FactorsPathogenicity
Enzymology22090027alpha-N-acetylgalactosaminidase from infant-associated bifidobacteria belonging to novel glycoside hydrolase family 129 is implicated in alternative mucin degradation pathway.Kiyohara M, Nakatomi T, Kurihara S, Fushinobu S, Suzuki H, Tanaka T, Shoda SI, Kitaoka M, Katayama T, Yamamoto K, Ashida HJ Biol Chem10.1074/jbc.M111.2773842011Bifidobacterium/cytology/*enzymology/genetics, Biocatalysis, Carbohydrate Sequence, Cloning, Molecular, Humans, Infant, Intracellular Space/enzymology, Molecular Sequence Data, Mucins/*metabolism, Phylogeny, *Proteolysis, alpha-N-Acetylgalactosaminidase/genetics/*metabolismMetabolism
Enzymology23089618Bifidobacterial alpha-galactosidase with unique carbohydrate-binding module specifically acts on blood group B antigen.Wakinaka T, Kiyohara M, Kurihara S, Hirata A, Chaiwangsri T, Ohnuma T, Fukamizo T, Katayama T, Ashida H, Yamamoto KGlycobiology10.1093/glycob/cws1422012ABO Blood-Group System/metabolism, Bifidobacterium/*enzymology, Blood Group Antigens/isolation & purification/metabolism, Escherichia coli/*enzymology, Humans, Infant, Infant, Newborn, Intestines/microbiology, Milk, Human/enzymology, Mucins/chemistry/metabolism, *Polysaccharides/chemistry/metabolism, Receptors, Cell Surface/genetics/isolation & purification, *alpha-Galactosidase/genetics/isolation & purification, beta-Galactosidase/chemistry/metabolismMetabolism
Enzymology23231860Hypolipidemic effects of lactic acid bacteria fermented cereal in rats.Banjoko IO, Adeyanju MM, Ademuyiwa O, Adebawo OO, Olalere RA, Kolawole MO, Adegbola IA, Adesanmi TA, Oladunjoye TO, Ogunnowo AA, Shorinola AA, Daropale O, Babatope EB, Osibogun AO, Ogunfowokan DT, Jentegbe TA, Apelehin TG, Ogunnowo O, Olokodana O, Fetuga FY, Omitola M, Okafor LA, Ebohon CL, Ita JO, Disu KA, Ogherebe O, Eriobu SU, Bakare AALipids Health Dis10.1186/1476-511X-11-1702012Animals, Bifidobacterium/enzymology, Diet, High-Fat, *Dyslipidemias/blood/drug therapy, Edible Grain/*chemistry, *Fermentation, Food Analysis, *Hypolipidemic Agents/chemistry/pharmacology, Lactic Acid/biosynthesis, Lactobacillus acidophilus/enzymology, Lactobacillus helveticus/enzymology, *Lipids/analysis/blood/chemistry, Rats
Metabolism23479733Crystal structures of a glycoside hydrolase family 20 lacto-N-biosidase from Bifidobacterium bifidum.Ito T, Katayama T, Hattie M, Sakurama H, Wada J, Suzuki R, Ashida H, Wakagi T, Yamamoto K, Stubbs KA, Fushinobu SJ Biol Chem10.1074/jbc.M112.4201092013Bacterial Proteins/*chemistry/metabolism, Bifidobacterium/*enzymology, Crystallography, X-Ray, Glycoside Hydrolases/*chemistry/metabolism, Humans, *Models, Molecular, *Protein Folding, Protein Structure, Secondary, Protein Structure, TertiaryPathogenicity
Metabolism25381911alpha-N-Acetylglucosaminidase from Bifidobacterium bifidum specifically hydrolyzes alpha-linked N-acetylglucosamine at nonreducing terminus of O-glycan on gastric mucin.Shimada Y, Watanabe Y, Wakinaka T, Funeno Y, Kubota M, Chaiwangsri T, Kurihara S, Yamamoto K, Katayama T, Ashida HAppl Microbiol Biotechnol10.1007/s00253-014-6201-x2014Acetylglucosamine/*metabolism, Acetylglucosaminidase/*metabolism, Bifidobacterium/*enzymology, Binding Sites, Gastric Mucins/*metabolismEnzymology
Enzymology27422836Efficient and Regioselective Synthesis of beta-GalNAc/GlcNAc-Lactose by a Bifunctional Transglycosylating beta-N-Acetylhexosaminidase from Bifidobacterium bifidum.Chen X, Xu L, Jin L, Sun B, Gu G, Lu L, Xiao MAppl Environ Microbiol10.1128/AEM.01325-162016Acetylgalactosamine/*metabolism, Acetylglucosamine/*metabolism, Bacteroides fragilis/enzymology/genetics, Bifidobacterium bifidum/*enzymology/genetics, Cloning, Molecular, Clostridium perfringens/enzymology/genetics, Enzyme Stability, Escherichia coli/genetics/metabolism, Gene Expression, Hydrogen-Ion Concentration, Kinetics, Lactose/*metabolism, Molecular Docking Simulation, Recombinant Proteins/chemistry/genetics/isolation & purification/metabolism, Temperature, beta-N-Acetylhexosaminidases/chemistry/genetics/isolation & purification/*metabolismMetabolism
Metabolism27832720Application study of 1,2-alpha-l-fucosynthase: introduction of Fucalpha1-2Gal disaccharide structures on N-glycan, ganglioside, and xyloglucan oligosaccharide.Sugiyama Y, Katoh T, Honda Y, Gotoh A, Ashida H, Kurihara S, Yamamoto K, Katayama TBiosci Biotechnol Biochem10.1080/09168451.2016.12545322016Asialoglycoproteins/metabolism, Bifidobacterium/enzymology, Disaccharides/*chemistry/*metabolism, Fetuins/metabolism, Fucose/*chemistry/metabolism, Gangliosides/*chemistry/metabolism, Glucans/*chemistry/metabolism, Glycolipids/chemistry/metabolism, Mutation, Oligosaccharides/*chemistry/metabolism, Plants/chemistry, Protein Engineering, Xylans/*chemistry/metabolism, alpha-L-Fucosidase/genetics/*metabolismEnzymology
Enzymology29678922Enzymatic Synthesis of 6'-Sialyllactose, a Dominant Sialylated Human Milk Oligosaccharide, by a Novel exo-alpha-Sialidase from Bacteroides fragilis NCTC9343.Guo L, Chen X, Xu L, Xiao M, Lu LAppl Environ Microbiol10.1128/AEM.00071-182018Bacteroides fragilis/*enzymology/*genetics, Bifidobacterium bifidum/enzymology/genetics, Cloning, Molecular, Clostridium perfringens/enzymology/genetics, Escherichia coli/genetics, Gene Expression Regulation, Bacterial, Humans, Hydrogen-Ion Concentration, Infant Formula, Lactose/*analogs & derivatives/biosynthesis/metabolism, Milk, Human/*chemistry, Models, Molecular, Molecular Weight, Neuraminidase/*genetics/isolation & purification/*metabolism, Oligosaccharides/*metabolism, Protein Domains, Recombinant Proteins, Sequence Alignment, Sequence Analysis, Sialic Acids/metabolism, Substrate Specificity, Temperature, Time FactorsMetabolism
Metabolism30919101The antioxidant and prebiotic properties of lactobionic acid.Goderska KAppl Microbiol Biotechnol10.1007/s00253-019-09754-72019Antioxidants/*chemistry/*metabolism, Disaccharides/*chemistry/*metabolism, Hot Temperature, Lactobacillus fermentum/growth & development/metabolism, Oxidation-Reduction, Peroxides/chemistry, Prebiotics/*analysis, Pseudomonas/*metabolism, Rapeseed Oil/chemistry, Whey/metabolism/*microbiology, Whey Proteins/metabolismStress
Enzymology31822984Converting a beta-N-acetylhexosaminidase into two trans-beta-N-acetylhexosaminidases by domain-targeted mutagenesis.Chen X, Jin L, Jiang X, Guo L, Gu G, Xu L, Lu L, Wang F, Xiao MAppl Microbiol Biotechnol10.1007/s00253-019-10253-y2019Bifidobacterium bifidum/*enzymology/genetics, Directed Molecular Evolution, Kinetics, Magnetic Resonance Spectroscopy, *Mutagenesis, Mutant Proteins/chemistry/*genetics/*metabolism, beta-N-Acetylhexosaminidases/chemistry/*genetics/*metabolismMetabolism
Pathogenicity32625197Bifidobacterium bifidum Suppresses Gut Inflammation Caused by Repeated Antibiotic Disturbance Without Recovering Gut Microbiome Diversity in Mice.Ojima MN, Gotoh A, Takada H, Odamaki T, Xiao JZ, Katoh T, Katayama TFront Microbiol10.3389/fmicb.2020.013492020
Metabolism33461001Influence of fucosidase-producing bifidobacteria on the HBGA antigenicity of oyster digestive tissue and the associated norovirus binding.Eshaghi Gorji M, Tan MTH, Li DInt J Food Microbiol10.1016/j.ijfoodmicro.2021.1090582021Animals, Antibodies, Monoclonal, Bifidobacterium/*enzymology/physiology, Blood Group Antigens/immunology/*metabolism, Humans, Intestines/immunology/virology, Norovirus/*metabolism, Ostreidae/immunology/*virology, Shellfish/*virology, alpha-L-Fucosidase/*metabolismPathogenicity
34282567Evaluation of Microencapsulated Synbiotic Preparations Containing Lactobionic Acid.Goderska K, Kozlowski PAppl Biochem Biotechnol10.1007/s12010-021-03622-92021*Bifidobacterium bifidum, Capsules, Disaccharides/*chemistry, *Lactobacillales, Probiotics/*chemistry, *Synbiotics

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
8509Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 20082)https://www.dsmz.de/collection/catalogue/details/culture/DSM-20082
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
36043Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/10169
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
67770Curators of the JCMhttps://jcm.brc.riken.jp/en/
68371Automatically annotated from API 50CH acid
68382Automatically annotated from API zym
69480Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesPredictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
69481Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch10.21203/rs.3.rs-2527258/v1Predictions based on the model GenomeNet Sporulation v. 1
71338Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID7403.1StrainInfo: A central database for resolving microbial strain identifiers
116807Curators of the CIPCollection of Institut Pasteur (CIP 64.64)https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%2064.64